🔬FDA Shifts Focus to Non-Animal Testing Methods
FDA now requires data from organs-on-a-chip
TL;DR
The FDA now requires data from organs-on-a-chip or comparable alternatives for drug safety testing, marking a significant shift from animal testing. This move could reduce drug development costs and improve accuracy.
The FDA has officially shifted its stance on drug safety testing, now mandating data from organs-on-a-chip or similar non-animal testing methods. This change, driven by the FDA Modernization Act 2.0, aims to reduce the reliance on animal testing and improve the accuracy of drug safety assessments. The move is significant for pharmaceutical companies and researchers, as it could lead to more efficient and cost-effective drug development processes. The FDA's rule, issued in September 2026, replaces references to 'animal tests' with the broader term 'nonclinical tests', signaling a broader acceptance of alternative testing methods.
Key Points
FDA Modernization Act 2.0 passed in late 2022, authorizing the use of non-animal testing methods in preclinical studies.
The FDA pledged to make animal studies the exception rather than the norm for drug safety testing by 2025.
The FDA issued a rule in September 2026 replacing 'animal tests' with 'nonclinical tests', broadening acceptance of alternatives.
The model human lung developed at Harvard in 2006, smaller than a USB stick, simulates lung function and has been cited in nearly 5,400 papers.
Organ-on-a-chip systems are used by pharmaceutical companies for drug testing, providing a complement to animal testing.
Why It Matters
If you're developing drugs, the FDA's shift to non-animal testing methods could drastically change your R&D process. The requirement for organs-on-a-chip or similar alternatives could reduce drug development costs and improve accuracy, but it also means you need to adapt your testing protocols. Early studies suggest that these new methods could be more reliable, but the adoption of NAMs will require changes in policy, training, and culture.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,568 builders reading daily.